Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 17

1.

Transformed Follicular Lymphoma (TFL) Predicts Outcome in Advanced Endometrial Cancer.

Wakahashi S, Kawakami F, Wakahashi K, Minagawa K, Matsuo K, Katayama Y, Yamada H, Matsui T, Sudo T.

Cancer Epidemiol Biomarkers Prev. 2018 May 21. doi: 10.1158/1055-9965.EPI-17-0762. [Epub ahead of print]

PMID:
29784731
2.

Diagnosis of desmoplastic small-round-cell tumor by cytogenetic analysis: a case report.

Wakahashi S, Sudo T, Ichida K, Sugita S, Hasegawa T, Nagao S, Yamaguchi S, Sakuma T, Yamada H.

Clin Case Rep. 2016 Apr 15;4(5):520-3. doi: 10.1002/ccr3.558. eCollection 2016 May.

3.

A preoperative low cancer antigen 125 level (≤25.8 mg/dl) is a useful criterion to determine the optimal timing of interval debulking surgery following neoadjuvant chemotherapy in epithelial ovarian cancer.

Morimoto A, Nagao S, Kogiku A, Yamamoto K, Miwa M, Wakahashi S, Ichida K, Sudo T, Yamaguchi S, Fujiwara K.

Jpn J Clin Oncol. 2016 Jun;46(6):517-21. doi: 10.1093/jjco/hyw029. Epub 2016 Mar 13.

PMID:
26977055
4.

Clinical Features of Neuroendocrine Carcinoma of the Uterine Cervix: A Single-Institution Retrospective Review.

Nagao S, Miwa M, Maeda N, Kogiku A, Yamamoto K, Morimoto A, Wakahashi S, Ichida K, Sudo T, Yamaguchi S, Sakuma T, Fujiwara K.

Int J Gynecol Cancer. 2015 Sep;25(7):1300-5. doi: 10.1097/IGC.0000000000000495.

PMID:
26166556
5.

Outcomes of Laser Conization for Cervical Intraepithelial Neoplasia 2-3 and Microinvasive Cervical Cancer.

Kanayama S, Nakagawa E, Ueno S, Muraji M, Wakahashi S, Sudo T, Yamada T, Yamaguchi S, Fujiwara K, Nishimura R.

World J Oncol. 2014 Apr;5(2):62-67. doi: 10.14740/wjon799w. Epub 2014 May 6.

6.

Histopathology predicts clinical outcome in advanced epithelial ovarian cancer patients treated with neoadjuvant chemotherapy and debulking surgery.

Muraji M, Sudo T, Iwasaki S, Ueno S, Wakahashi S, Yamaguchi S, Fujiwara K, Nishimura R.

Gynecol Oncol. 2013 Dec;131(3):531-4. doi: 10.1016/j.ygyno.2013.09.030. Epub 2013 Oct 4.

PMID:
24096109
7.

VAV1 represses E-cadherin expression through the transactivation of Snail and Slug: a potential mechanism for aberrant epithelial to mesenchymal transition in human epithelial ovarian cancer.

Wakahashi S, Sudo T, Oka N, Ueno S, Yamaguchi S, Fujiwara K, Ohbayashi C, Nishimura R.

Transl Res. 2013 Sep;162(3):181-90. doi: 10.1016/j.trsl.2013.06.005. Epub 2013 Jul 12.

PMID:
23856093
8.

Absence of human papillomavirus infection and activation of PI3K-AKT pathway in cervical clear cell carcinoma.

Ueno S, Sudo T, Oka N, Wakahashi S, Yamaguchi S, Fujiwara K, Mikami Y, Nishimura R.

Int J Gynecol Cancer. 2013 Jul;23(6):1084-91. doi: 10.1097/IGC.0b013e3182981bdc.

PMID:
23792604
9.

Endometrial stromal sarcoma: clinicopathological and immunophenotypic study of 16 cases.

Iwasaki S, Sudo T, Miwa M, Ukita M, Morimoto A, Tamada M, Ueno S, Wakahashi S, Yamaguchi S, Fujiwara K, Sakuma Y, Mikami Y, Nishimura R.

Arch Gynecol Obstet. 2013 Aug;288(2):385-91. doi: 10.1007/s00404-013-2766-3. Epub 2013 Feb 23.

PMID:
23435725
10.

The effect of abdominal radical trachelectomy on ovarian reserve: serial changes in serum anti-müllerian hormone levels.

Muraji M, Sudo T, Iwasaki S, Ueno S, Wakahashi S, Yamaguchi S, Fujiwara K, Nishimura R.

J Cancer. 2012;3:191-5. doi: 10.7150/jca.4316. Epub 2012 May 3.

11.

Type II versus type III fertility-sparing abdominal radical trachelectomy for early-stage cervical cancer: a comparison of feasibility of surgical outcomes.

Muraji M, Sudo T, Nakagawa E, Ueno S, Wakahashi S, Kanayama S, Yamada T, Yamaguchi S, Fujiwara K, Nishimura R.

Int J Gynecol Cancer. 2012 Mar;22(3):479-83. doi: 10.1097/IGC.0b013e31823fa7bd.

PMID:
22214963
12.

Endometrioid adenocarcinoma with high-grade transformation with serous and choriocarcinomatous differentiation - a case report.

Wakahashi S, Sudo T, Nakagawa E, Ueno S, Muraji M, Kanayama S, Itami H, Kawakami F, Yamada T, Yamaguchi S, Fujiwara K, Nishikawa H, Nishimura R, Ohbayashi C.

J Cancer. 2012;3:14-8. Epub 2011 Dec 1.

13.

Suppression of progesterone production by stresscopin/urocortin 3 in cultured human granulosa-lutein cells.

Yata A, Nakabayashi K, Wakahashi S, Maruo N, Ohara N, Maruo T.

Hum Reprod. 2009 Jul;24(7):1748-53. doi: 10.1093/humrep/dep063. Epub 2009 Apr 7.

PMID:
19351656
14.

Effects of corticotropin-releasing hormone and stresscopin on vascular endothelial growth factor mRNA expression in cultured early human extravillous trophoblasts.

Wakahashi S, Nakabayashi K, Maruo N, Yata A, Ohara N, Maruo T.

Endocrine. 2008 Apr;33(2):144-51. doi: 10.1007/s12020-008-9071-0. Epub 2008 May 17.

PMID:
18484196
15.

Effects of recombinant H2 relaxin on the expression of matrix metalloproteinases and tissue inhibitor metalloproteinase in cultured early placental extravillous trophoblasts.

Maruo N, Nakabayashi K, Wakahashi S, Yata A, Maruo T.

Endocrine. 2007 Dec;32(3):303-10. doi: 10.1007/s12020-008-9034-5. Epub 2008 Jan 31.

PMID:
18236174
16.

A case of virilizing brenner tumor in a postmenopausal woman with stromal androgenic activity.

Takeuchi K, Kitazawa S, Wakahashi S, Sugimoto M, Morizane M, Maruo T.

Int J Gynecol Pathol. 2006 Jul;25(3):230-2.

PMID:
16810058
17.

Uterine bizarre epithelioid lipoleiomyoma with a myxoid stroma.

Takeuchi K, Kitazawa S, Tsujino T, Wakahashi S, Maruo T.

Eur J Gynaecol Oncol. 2006;27(3):273-4.

PMID:
16800257

Supplemental Content

Loading ...
Support Center